Evaluation of a Habit-based Work-up to Support Medication Adherence

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to test the impact of a medication-taking habit worksheet and discussion with a pharmacist in patients who are prescribed a new chronic medication for cardiovascular disease or depression. The main questions it aims to answer are: - What is the feasibility and acceptability of the workup from the perspective of the patients and the clinic? - What is the impact of the intervention on the formation of medication-taking habits compared to a comparison group who receive standard pharmacist counseling? - What is the difference in medication adherence beliefs and behaviors for the group receiving the habit workup compared to those receiving standard counseling?

Clinical Trial Description

The purpose of this study is to evaluate a habit adherence workup delivered by pharmacy in primary care. The study population will include patients taking new medications for chronic conditions like high blood pressure, high cholesterol, diabetes, and depression. This study uses a sequential design which involves first evaluating 16 patients without the added habit worksheet, and then the second phase evaluates 16 patients with the habit worksheet. All participants meet with the pharmacist and are provided standard counseling on the new medications. All participants complete the pre and post survey. The pharmacist will be trained on the medication habit workup worksheet which has the patient choose cues they will use to develop their medication-taking habit. These will include associating the new habit with hygiene habits like toothbrushing, other habits like making coffee or eating breakfast, or visual cues like setting medications out where they will be easily noticed when doing other habits like getting dressed. Patients will take their sheet with them as a reminder of their plan. Patients also will receive medication counseling. The encounters will occur in a private clinic room. All participants will complete baseline and follow-up surveys, which will include space for open-ended comments. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06230978
Study type	Interventional
Source	University of Iowa
Contact	Matthew J Witry, PhD
Phone	319-335-8763
Email	matthew-witry@uiowa.edu
Status	Recruiting
Phase	N/A
Start date	April 1, 2024
Completion date	August 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04709640` - Pilot Study to Improve Medication Management in Older Adults	N/A
Completed	`NCT03257579` - Myocardial Infarction Prescription Duration Adherence Study	N/A
Completed	`NCT05376397` - Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)	N/A
Withdrawn	`NCT03427008` - A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients	N/A
Completed	`NCT03805451` - Life Steps for PrEP for Youth	N/A
Withdrawn	`NCT03292393` - Social Norms and Antihypertensive Medication Adherence	N/A
Not yet recruiting	`NCT02876848` - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)	N/A
Completed	`NCT02823795` - The Supporting Patient Activation in Transition to Home Intervention	N/A
Completed	`NCT02914730` - Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
Completed	`NCT02797262` - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System	N/A
Completed	`NCT02066935` - Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study
Completed	`NCT01934608` - The Effect of Synching Prescription Refills on Adherence	N/A
Completed	`NCT01770314` - Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.	Phase 2
Completed	`NCT01741311` - Secondary HIV Prevention and Adherence Among HIV-infected Drug Users	N/A
Recruiting	`NCT01105104` - An Enhanced Medication Monitoring Program	Phase 1
Completed	`NCT01859273` - Adherence Enhancement for Renal Transplant Patients	N/A
Withdrawn	`NCT01430702` - Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults	N/A
Completed	`NCT01118208` - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response	N/A
Completed	`NCT00848224` - Improving Adherence to Pharmacological Treatment	N/A
Completed	`NCT06034301` - Pill Bottle vs Reminder App	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.